Ceplac tests cocoa clones in neighboring countries against moniliasis

Published 2024년 10월 28일

Tridge summary

The Executive Committee of the Cocoa Crop Plan (Ceplac) is collaborating with institutions in Ecuador and Costa Rica to test 128 cocoa clones for resistance to moniliasis, a disease that poses a threat to Brazil's cocoa industry. These clones have been developed over the past 15 years, incorporating resistance sources from Ecuador, Costa Rica, Peru, and Trinidad and Tobago. The clones are being tested in regions with severe disease presence, as part of a comprehensive research program aimed at developing resistant varieties, which includes studies on the fungus' genomic knowledge, rapid detection kits, biological control agents, and successful control measures from other countries.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

As part of the strategies to protect the national cocoa industry against moniliasis, the Executive Committee of the Cocoa Crop Plan (Ceplac) sent cocoa clones for testing in Ecuador and Costa Rica. The action is carried out in partnership with the National Institute of Agricultural Research of Ecuador (Iniap) and the Agronomic Center for Tropical Research and Education of Costa Rica (Catie) and is part of a research program that aims to reduce the impacts of the presence of moniliasis in Brazil. Developed over the last 15 years by Ceplac, involving sources of resistance to moniliasis introduced from Ecuador, Costa Rica, Peru and Trinidad and Tobago, and to other diseases, the 128 clones were sent for testing in areas where the disease is highly severe. To ensure agricultural safety, the samples were quarantined for approximately five years by the National Center for Genetic Resources (Cenargem) of the Brazilian Agricultural Research Corporation (Embrapa). Considered one of the ...

Source: NoticiasAgricolas